{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:32:27Z","timestamp":1786116747438,"version":"build-2736575974"},"reference-count":109,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clp.2026.04.007","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:43:08Z","timestamp":1780519388000},"page":"565-581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of Viral Infections During Pregnancy"],"prefix":"10.1016","volume":"53","author":[{"given":"Angela M.","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol R.","family":"Norwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clp.2026.04.007_bib3","first-page":"218","article-title":"Estimated number of infants born to HIV-infected women in the United States and five dependent areas, 2006","volume":"57","author":"Whitmore","year":"2011","journal-title":"J AIDS HIV"},{"key":"10.1016\/j.clp.2026.04.007_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000040339","article-title":"Prevalence of HIV\/AIDS among pregnant women in North American region: a systematic review and meta-analysis","volume":"103","author":"Shabbir","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.clp.2026.04.007_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/AOG.0000000000003048","article-title":"ACOG Committee Opinion No. 752: prenatal and perinatal human immunodeficiency virus testing","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.007_bib7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/QAD.0000000000003215","article-title":"Predictors of adverse pregnancy outcomes among Kenyan women with HIV on antiretroviral treatment in pregnancy","volume":"36","author":"Jiang","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2026.04.007_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ijgo.15528","article-title":"Impact of maternal HIV infection on perinatal outcomes: a systematic review","volume":"166","author":"Atowoju","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.clp.2026.04.007_bib9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/QAD.0000000000004104","article-title":"Perinatal outcomes among pregnant women with HIV initiating antiretroviral therapy preconception and antenatally","volume":"39","author":"Boering","year":"2025","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2026.04.007_bib10","first-page":"506","article-title":"Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies","volume":"8","year":"1995","journal-title":"J AIDS Hum Retrovirol"},{"key":"10.1016\/j.clp.2026.04.007_bib11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group","volume":"331","author":"Connor","year":"1994","journal-title":"NEJM"},{"key":"10.1016\/j.clp.2026.04.007_bib12","first-page":"484","article-title":"Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission","volume":"29","author":"Cooper","year":"2002","journal-title":"J AIDS HIV"},{"key":"10.1016\/j.clp.2026.04.007_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/QAD.0b013e328350995c","article-title":"A national review of vertical HIV transmission","volume":"26","author":"Forbes","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2026.04.007_bib14","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/cid\/civ578","article-title":"No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception","volume":"61","author":"Mandelbrot","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM199908053410601","article-title":"Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine","volume":"341","author":"Mofenson","year":"1999","journal-title":"NEJM"},{"key":"10.1016\/j.clp.2026.04.007_bib17","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/QAD.0000000000000212","article-title":"Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011","volume":"28","author":"Townsend","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2026.04.007_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(25)00132-8","article-title":"Probability of vertical HIV transmission: a systematic review and meta-regression","author":"Walters","year":"2025","journal-title":"Lancet HIV"},{"key":"10.1016\/j.clp.2026.04.007_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(25)00765-2","article-title":"Estimating the effect of maternal viral load on perinatal and postnatal HIV transmission: a systematic review and meta-analysis","volume":"406","author":"Dugdale","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2026.04.007_bib20","first-page":"35","article-title":"Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa","volume":"54","author":"Hoffman","year":"2010","journal-title":"J AIDS HIV"},{"key":"10.1016\/j.clp.2026.04.007_bib21","first-page":"CD003510","article-title":"Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection","volume":"7","author":"Siegfried","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2026.04.007_bib22","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1511691","article-title":"Benefits and risks of antiretroviral therapy for perinatal HIV prevention","volume":"375","author":"Fowler","year":"2016","journal-title":"NEJM"},{"key":"10.1016\/j.clp.2026.04.007_bib23","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1056\/NEJMoa1108275","article-title":"Three postpartum antiretroviral regimens to prevent intrapartum HIV infection","volume":"366","author":"Nielsen-Saines","year":"2012","journal-title":"NEJM"},{"key":"10.1016\/j.clp.2026.04.007_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/cid\/cit374","article-title":"Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?","volume":"57","author":"Briand","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/650005","article-title":"Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 Copies\/mL at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1)","volume":"50","author":"Tubiana","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/317918","article-title":"Correlates of mother-to-child human immunodeficiency virus type 1 transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections","volume":"183","author":"John","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/QAD.0b013e32801424bd","article-title":"Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding","volume":"21","author":"Graham","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2026.04.007_bib28","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/00002030-200310170-00004","article-title":"Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies","volume":"17","author":"Fiore","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2026.04.007_bib29","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/infdis\/jix550","article-title":"Prevalence, magnitude, and correlates of HIV-1 genital shedding in women on antiretroviral therapy","volume":"216","author":"King","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib30","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1097\/QAD.0b013e32833e5043","article-title":"Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load","volume":"24","author":"Cu-Uvin","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2026.04.007_bib31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3851\/IMP1856","article-title":"Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study","volume":"16","author":"Launay","year":"2011","journal-title":"Antivir Ther"},{"key":"10.1016\/j.clp.2026.04.007_bib32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40262-014-0185-7","article-title":"Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals","volume":"53","author":"McCormack","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clp.2026.04.007_bib36","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1056\/NEJMc1807653","article-title":"Neural-tube defects with dolutegravir treatment from the time of conception","volume":"379","author":"Zash","year":"2018","journal-title":"NEJM"},{"key":"10.1016\/j.clp.2026.04.007_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/INF.0b013e318235c7aa","article-title":"Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals","volume":"31","author":"Knapp","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clp.2026.04.007_bib38","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/INF.0b013e3181e74a2f","article-title":"Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C","volume":"29","author":"Brogly","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clp.2026.04.007_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jamapediatrics.2014.1889","article-title":"Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants","volume":"169","author":"Williams","year":"2015","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.clp.2026.04.007_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001635","article-title":"Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1\/CO11)","volume":"11","author":"Sibiude","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.clp.2026.04.007_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/cid\/civ260","article-title":"In Utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial","volume":"61","author":"Sibiude","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib42","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1471-0528.2010.02689.x","article-title":"Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe","volume":"117","author":"Townsend","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.clp.2026.04.007_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QAD.0b013e32802ef2f6","article-title":"Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis","volume":"21","author":"Kourtis","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2026.04.007_bib44","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2352-3018(15)00207-6","article-title":"Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis","volume":"3","author":"Wedi","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.clp.2026.04.007_bib45","first-page":"367","article-title":"PMTCT option B1 does not increase preterm birth risk and may prevent extreme prematurity: a retrospective cohort study in Malawi","volume":"74","author":"Chagomerana","year":"2017","journal-title":"J AIDS HIV"},{"key":"10.1016\/j.clp.2026.04.007_bib46","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1542\/peds.2006-1123","article-title":"Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: pediatric spectrum of HIV disease, 1989-2004","volume":"119","author":"Schulte","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2026.04.007_bib47","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1086\/503045","article-title":"Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?","volume":"193","author":"Cotter","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib48","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/jir307","article-title":"Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy","volume":"204","author":"Powis","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib49","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/QAD.0b013e32830b8ab9","article-title":"Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, C\u00f4te d\u2019ivoire","volume":"22","author":"Ekouevi","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2026.04.007_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150565","article-title":"Preterm birth and low birth weight after in utero exposure to antiretrovirals initiated during pregnancy in Yaound\u00e9, Cameroon","volume":"11","author":"Njom Nlend","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clp.2026.04.007_bib51","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/QAD.0b013e32832be0df","article-title":"No relation between in-utero exposure to HAART and intrauterine growth retardation","volume":"23","author":"Briand","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2026.04.007_bib52","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa991159","article-title":"Antiretroviral therapy during pregnancy and the risk of an adverse outcome","volume":"346","author":"Tuomala","year":"2002","journal-title":"NEJM"},{"key":"10.1016\/j.clp.2026.04.007_bib53","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/01.aids.0000253362.01696.9d","article-title":"Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth","volume":"20","author":"Szyld","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2026.04.007_bib54","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1097\/AOG.0000000000002820","article-title":"ACOG Committee Opinion No. 751: labor and delivery management of women with human immunodeficiency virus infection","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.007_bib55","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/GRF.0000000000000887","article-title":"Updates in the management of HIV during pregnancy","volume":"67","author":"Benson","year":"2024","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.007_bib56","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(99)80008-7","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial","volume":"354","author":"Guay","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2026.04.007_bib57","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1086\/420834","article-title":"Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis","volume":"189","author":"Read","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib58","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/cid\/cix1102","article-title":"Contribution of maternal antiretroviral therapy and breastfeeding to 24-month survival in human immunodeficiency virus-exposed uninfected children: an individual pooled analysis of African and Asian studies","volume":"66","author":"Arikawa","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib59","first-page":"576","article-title":"Updated guidelines on infant feeding and HIV in the United States: what are they and why have recommendations changed","volume":"31","author":"Pollock","year":"2023","journal-title":"Top Antivir Med"},{"key":"10.1016\/j.clp.2026.04.007_bib60","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-066843","article-title":"Infant feeding for persons living with and at risk for HIV in the United States: clinical report","volume":"153","author":"Abuogi","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2026.04.007_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034635","article-title":"Infant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trial","volume":"7","author":"Drake","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clp.2026.04.007_bib62","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa0907736","article-title":"Antiretroviral regimens in pregnancy and breast-feeding in Botswana","volume":"362","author":"Shapiro","year":"2010","journal-title":"NEJM"},{"key":"10.1016\/j.clp.2026.04.007_bib63","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/INF.0b013e3181950c56","article-title":"Increased infant human immunodeficiency virus-type one free survival at one year of age in Sub-Saharan Africa with maternal use of highly active antiretroviral therapy during breastfeeding","volume":"28","author":"Marazzi","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clp.2026.04.007_bib64","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1086\/374273","article-title":"Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease","volume":"187","author":"Rousseau","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib65","first-page":"383","article-title":"Prevention of HIV-1 transmission through breastfeeding","volume":"77","author":"Flynn","year":"2018","journal-title":"J AIDS HIV"},{"key":"10.1016\/j.clp.2026.04.007_bib66","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa0911486","article-title":"Maternal or infant antiretroviral drugs to reduce HIV-1 transmission","volume":"362","author":"Chasela","year":"2010","journal-title":"NEJM"},{"key":"10.1016\/j.clp.2026.04.007_bib67","article-title":"Antiretroviral interventions for preventing breast milk transmission of HIV","volume":"10","author":"White","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2026.04.007_bib68","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/cid\/cix820","article-title":"Impact of timing of antiretroviral treatment and birth weight on mother-to-child human immunodeficiency virus transmission","volume":"66","author":"Dinh","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1473-3099(10)70288-7","article-title":"Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial","volume":"11","author":"de Vincenzi","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib70","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/jac\/dkv080","article-title":"Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important?","volume":"70","author":"Waitt","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clp.2026.04.007_bib71","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jac\/dkx507","article-title":"Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother-infant pairs","volume":"73","author":"Waitt","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clp.2026.04.007_bib72","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3851\/IMP2739","article-title":"Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study","volume":"19","author":"Corbett","year":"2014","journal-title":"Antivir Ther"},{"key":"10.1016\/j.clp.2026.04.007_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002132","article-title":"Pre-exposure prophylaxis use by breastfeeding HIV-uninfected women: a prospective short-term study of antiretroviral excretion in breast milk and infant absorption","volume":"13","author":"Mugwanya","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.clp.2026.04.007_bib74","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/jac\/dkv435","article-title":"Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the option B-plus approach in Malawi","volume":"71","author":"Palombi","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clp.2026.04.007_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000430","article-title":"HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis","volume":"8","author":"Zeh","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.clp.2026.04.007_bib76","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/cid\/cir008","article-title":"Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants","volume":"52","author":"Fogel","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib78","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cmi.2023.03.002","article-title":"Prevalence of human immunodeficiency virus, syphilis, and hepatitis B and C virus infections in pregnant women: a systematic review and meta-analysis","volume":"29","author":"Wu","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clp.2026.04.007_bib79","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/INF.0b013e31820cd65c","article-title":"Estimating the number of births to hepatitis B virus-infected women in 22 states, 2006","volume":"30","author":"Din","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clp.2026.04.007_bib80","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/AOG.0000000000003644","article-title":"Reported prevalence of maternal hepatitis C virus infection in the United States","volume":"135","author":"Rossi","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.007_bib81","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.24770","article-title":"Trends in the prevalence of hepatitis C infection during pregnancy and maternal-infant outcomes in the US, 1998 to 2018","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clp.2026.04.007_bib83","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/AOG.0000000000005300","article-title":"Viral hepatitis in pregnancy","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.007_bib84","doi-asserted-by":"crossref","first-page":"B8","DOI":"10.1016\/j.ajog.2021.06.008","article-title":"Smfm #56: hepatitis C in pregnancy-updated guidelines","volume":"225","author":"Dotters-Katz","year":"2021","journal-title":"AJOG"},{"key":"10.1016\/j.clp.2026.04.007_bib85","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2023.12.023","article-title":"Smfm #69: hepatitis B in pregnancy: updated guidelines","volume":"230","author":"Badell","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.007_bib86","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/jama.2019.9365","article-title":"Screening for hepatitis B virus infection in pregnant women: USPSTF recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2026.04.007_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","article-title":"Screening and testing for hepatitis B virus infection: CDC recommendations\u2014United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.clp.2026.04.007_bib88","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2013.11.008","article-title":"Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers","volume":"60","author":"Yi","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.clp.2026.04.007_bib89","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy134","article-title":"Maternal hepatitis B infection and pregnancy outcomes in the United States: a population-based cohort study","volume":"5","author":"Bajema","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.clp.2026.04.007_bib90","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.tjog.2021.08.006","article-title":"Relationship between viral load and pregnancy outcomes among hepatitis B carriers","volume":"61","author":"Cheung","year":"2022","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.007_bib91","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1186\/s12884-020-03257-4","article-title":"Maternal HBsAg carriers and pregnancy outcomes: a retrospective cohort analysis of 85,190 pregnancies","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.clp.2026.04.007_bib92","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/pathogens13040321","article-title":"Hepatitis C prevalence and birth outcomes among pregnant women in the United States: a 2010-2020 population study","volume":"13","author":"Wasuwanich","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.clp.2026.04.007_bib93","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510310328","article-title":"Prevalence and clinical course of chronic hepatitis C virus infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women","volume":"31","author":"Conte","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.clp.2026.04.007_bib94","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1002\/hep.22931","article-title":"Indications for therapy in hepatitis B","volume":"49","author":"Degertekin","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clp.2026.04.007_bib96","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajog.2015.09.100","article-title":"Smf #38: hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission","volume":"214","author":"Dionne-Odom","year":"2016","journal-title":"AJOG"},{"key":"10.1016\/j.clp.2026.04.007_bib97","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Part 1: immunization of infants, children, and adolescents","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.clp.2026.04.007_bib98","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/oxfordjournals.aje.a112370","article-title":"The e antigen and vertical transmission of hepatitis B surface antigen","volume":"105","author":"Beasley","year":"1977","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clp.2026.04.007_bib99","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1365-2893.2011.01492.x","article-title":"Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers","volume":"19","author":"Zou","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clp.2026.04.007_bib100","doi-asserted-by":"crossref","first-page":"828","DOI":"10.7326\/M13-2529","article-title":"Prevention of vertical transmission of hepatitis B","volume":"160","author":"Kubo","year":"2014","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.clp.2026.04.007_bib101","first-page":"CD008545","article-title":"Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus","author":"Eke","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2026.04.007_bib102","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2893.2006.00738.x","article-title":"Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study","volume":"13","author":"Yuan","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clp.2026.04.007_bib103","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clp.2026.04.007_bib104","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to prevent hepatitis B transmission in mothers with high viral load","volume":"374","author":"Pan","year":"2016","journal-title":"NEJM"},{"key":"10.1016\/j.clp.2026.04.007_bib105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/apt.70173","article-title":"Tenofovir alafenamide therapy throughout pregnancy in mothers with hepatitis B","volume":"62","author":"Pan","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clp.2026.04.007_bib106","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.3748\/wjg.v17.i38.4321","article-title":"A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus","volume":"17","author":"Han","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clp.2026.04.007_bib107","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/AOG.0b013e3181e45951","article-title":"Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus","volume":"116","author":"Shi","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.007_bib108","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/hep.27837","article-title":"Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus","volume":"62","author":"Chen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.clp.2026.04.007_bib109","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1708131","article-title":"Tenofovir versus placebo to prevent perinatal transmission of hepatitis B","volume":"378","author":"Jourdain","year":"2018","journal-title":"NEJM"},{"key":"10.1016\/j.clp.2026.04.007_bib110","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMc1805396","article-title":"Tenofovir to prevent perinatal transmission of hepatitis B","volume":"378","author":"Terrault","year":"2018","journal-title":"NEJM"},{"key":"10.1016\/j.clp.2026.04.007_bib111","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/aogs.14448","article-title":"Incidence of mother-to-child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: a systematic review and meta-analysis","volume":"101","author":"Yao","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.clp.2026.04.007_bib112","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12962-018-0088-9","article-title":"Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea","volume":"16","author":"Lee","year":"2018","journal-title":"Cost Eff Resour Allocation"},{"key":"10.1016\/j.clp.2026.04.007_bib113","doi-asserted-by":"crossref","first-page":"231.e1","DOI":"10.1016\/j.ajog.2012.06.001","article-title":"Antenatal lamivudine to reduce perinatal hepatitis B transmission: a cost-effectiveness analysis","volume":"207","author":"Nayeri","year":"2012","journal-title":"AJOG"},{"key":"10.1016\/j.clp.2026.04.007_bib114","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.clp.2026.04.007_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.clp.2026.04.007_bib116","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/AOG.0000000000005306","article-title":"Risk factors for perinatal transmission of hepatitis C virus","volume":"142","author":"Prasad","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.007_bib119","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3390\/pathogens13060508","article-title":"Direct-acting antiviral agents in prevention of maternal-fetal transmission of hepatitis C virus in pregnancy","volume":"13","author":"Hartley","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.clp.2026.04.007_bib120","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.07.039","article-title":"Hepatitis C in pregnancy: screening, treatment, and management","volume":"217","author":"Hughes","year":"2017","journal-title":"AJOG"},{"key":"10.1016\/j.clp.2026.04.007_bib121","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1097\/AOG.0000000000002662","article-title":"Maternal immunization","volume":"131","year":"2018","journal-title":"Obstet Gynecol"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:14:51Z","timestamp":1786018491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510826000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":109,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0095510826000369"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2026.04.007","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Viral Infections During Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2026.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}